Judge Overturns Purdue Pharma's Opioid Settlement
2021
This news article from The New York Times describes the overturning of the opioid settlement involving the pharmaceutical company Purdue Pharma, the maker of the prescription drug OxyContin in 2021. Purdue, which faced thousands of civil lawsuits for the company’s role in the opioid epidemic, filed for bankruptcy in September 2019–to protect the company’s owners from civil lawsuits or liability in opioid-related cases in return for a $4.5 billion contribution. The article provides the details of the case and the ruling, documenting litigation seeking accountability for the role of pharmaceutical companies in contributing to the opioid epidemic in the United States.
Judge Overturns Purdue Pharma's Opioid Settlement
Source:
Hoffman J. Judge Overturns Purdue Pharma’s Opioid Settlement. The New York Times 2021; Dec 16. https://www.nytimes.com/2021/12/16/health/purdue-pharma-opioid-settlement.html.